Providing stock analysis for investors of the Canadian junior markets
Cognetivity Neurosciences (CSE: CGN) this morning announced that it has seen another publication of a scientific paper on its assessment
Read more
Monday was a very big day for companies who are in the business to help patients who suffer from Alzheimer’s,
Read more
Cognetivity Neurosciences (CSE: CGN) this morning announced that it has filed for a key new patent. The filing relates to
Read more
For the final episode of The Deep Dive this week, we sit down with Sina Habibi, CEO of Cognetivity Neurosciences
Read more
On Friday, Echelon Capital Markets initiated coverage on Cognetivity Neurosciences (CSE: CGN) with a speculative buy rating and C$0.85 12-month
Read more
Cognetivity Neurosciences (CSE: CGN) this morning announced that it has added a former UK Health Minister to its advisory board.
Read more
Cognetivity Neurosciences (CSE: CGN) has reached the commercialization stage for one of its products. The company this morning announced that
Read more
Joining us at the midpoint of the week on the Daily Dive, is that of Dr Thomas Sawyer, COO of
Read more
Cognetivity Neurosciences (CSE: CGN) this morning announced the expansion of an ongoing study in the UK related to its cognitive
Read more
Cognetivity Neurosciences (CSE: CGN) has been selected as one of just seven members of the Texas Medical Center Innovation Accelerator
Read more